Latest Case Studies

    Mar 24, 2023

    Expanding the reach of clinical trials

    Immunogenicity biomarkers in individuals previously infected with COVID-19 were used to evaluate vaccines in preclinical and clinical trials.

    Mar 24, 2023

    Linking a drug mechanism to a human disease

    A specific autoimmune indication was identified for a novel therapy using patient donor biospecimens.

    Mar 24, 2023

    Describing the patient experience in biomarkers

    A prospective, longitudinal study using in-home collected biospecimens identified a panel of predictive biomarkers.

    Jan 15, 2023

    Building Confidence for First-in-Human Trials

    Confirming preclinical pharmacology in whole blood from MS patients.

    Apr 24, 2021

    Hybrid by Design: Patient Centricity in Clinical Trials

    As an X-linked disorder, Duchenne’s muscular dystrophy (DMD) primarily affects males, with an incidence of one in every…